Volume 6, Issue 3 (11-2016)                   JABS 2016, 6(3): 283-295 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sharifi N, Fath Nejad Kazemi A, Ghafari-Novin M. Infertility, Ovulation Induction, and Cancers Risk in Women: Review Article. JABS 2016; 6 (3) :283-295
URL: http://jabs.fums.ac.ir/article-1-942-en.html
1- Student Research office,school of nursing & midwifery Shahid beheshti University of Medical Sciences, Tehran, Iran.
2- Department of Midwifery, Tabriz Branch, Islamic Azad University, Tabriz, Iran. , afnkazemi@gmail.com
3- Depatment of Reproductive Endocrinology and Embryology, Infertility Fertility Research Centre, Shahid beheshti University of Medical Sciences, Tehran, Iran.
Abstract:   (11634 Views)

Background & Objective: Using fertility treatment has increased markedly in recent decades. However, various concerns associated with the use of fertility drugs, such as increased risk of cancer, has developed. The objective of the present study is to overview studies in the field of infertility, ovulation induction, and its impact on cancer risks in women.

Material & Methods: This study is a review of all articles published during the years 1995 and 2014 through databases SID, magiran, Medlib, pubmed, Scopus, Google Scholar, and Science Direct. Comprehensive search was done with the keywords of infertility, ovulation induction, the risk of cancer, gynecological cancer, clomiphene citrate, human chorionic gonadotropin, uterine cancer, ovarian cancer, and breast cancer for Persian articles and their English equivalents for English articles. After reviewing, a total of 79 articles were included in the study.

Results: Various studies revealed the possibility of an increased risk of uterine, ovarian, and breast cancer and hormonal changes associated with ovulation stimulation. But these results are not conclusive because of small sample size, short follow-up periods, and vague information about the type and the way drug is consumed.

Conclusion: Mainly women's cancer are associated with hormonal issues. Controversy over research results requisite further evaluation in order to investigate the impact of ovulation-inducing drugs on cancer risk which needs a well designed study.

Full-Text [PDF 1593 kb]   (7470 Downloads)    
Type of Study: Review | Subject: Gynecology & Obstetrics
Received: 2015/10/25 | Accepted: 2016/06/11 | Published: 2016/12/12

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advanced Biomedical Sciences

Designed & Developed by: Yektaweb

Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)